Invention Grant
US08729072B2 Alkylated piperazine compounds 有权
烷基化哌嗪化合物

Alkylated piperazine compounds
Abstract:
Alkylated piperazine compounds of Formula I are provided, including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
Public/Granted literature
Information query
Patent Agency Ranking
0/0